期刊文献+

动态观察降钙素原在90例新生儿感染鉴别及治疗中的价值 被引量:4

下载PDF
导出
摘要 目的了解动态检测降钙素原在新生儿感染性疾病中诊断及治疗中的意义。方法将2010年9月至2011年9月对以新生儿感染为诊断在我院新生儿重症监护室中住院治疗的90例新生儿进行降钙素原的测定,并与未感染者进行比较,将治疗前后的降钙素原进行比较,对照组与确诊新生儿细菌感染的治疗后的患儿进行比较。结论细菌感染时患儿血清中的降钙素原(PCT)水平会升高,特别是患有新生儿败血症等严重细菌感染症时升高尤为明显,可作为早期新生儿细菌感染的测量指标,并且动态观察血清降钙素原可判断感染程度严重与否及抗生素疗效,从而提高新生儿早期感染疾病诊断率。
作者 聂韵 傅万海
出处 《中国医学工程》 2012年第5期138-139,共2页 China Medical Engineering
  • 相关文献

参考文献8

二级参考文献35

  • 1栾江威,李翠华,熊嗣玉.原发性肾病综合征患儿血尿IL-6和TNF-α含量变化及意义[J].新乡医学院学报,2000,17(6):415-417. 被引量:5
  • 2徐敬,舒礼良,赵文增,杨栋.婴幼儿围体外循环期肿瘤坏死因子-α、白细胞介素-8、白细胞介素-10的变化[J].实用儿科临床杂志,2004,19(7):597-598. 被引量:5
  • 3Snider RH Jr, Nylen ES, Becket KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization[J]. J Investig Med, 1997,45(9) :552-560.
  • 4Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the caleitonink-1 gene in multiple tissues in response to sepsis[J]. J Clin Endocrinol Metab, 2001,86( 1 ) :396-404.
  • 5Oberhoffer M, Stonans I, Russwt, rm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitra[J]. J Lab Clin Med, 1999.134(1 ) :49-55.
  • 6Whang KT, Vath SD,Becker KL, et al.Procalcitoin and proinflammatory cytokine interactions in sepsis[ J].Shock, 2000,14(1 ) :73-78.
  • 7Nylen ES, Whang KT, Snider RH Jr, et al. Mortality is increased byprocalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis[ J]. Crit Care Med, 1998,26 (6) : 1001-1006.
  • 8Martinez JM, Becket KL, Mailer B, et al. Improved physiologic and metabolic parameters and increased survival with late procaleiton in immunoneutralization in septic pigs. In : 41 st Interscience Conference on Antimicrehiol Agents and Chemotherapy (ICAAC). Chicago, IL,2001.
  • 9Brunkhorst FM, Heins U, Forycki ZF. Kinetics of pmcalcitonin in iatrogenic sepsis[ J]. Intensive Care Med, 1998,24(8) :888-889.
  • 10Schroder J, Staubach KH, Zabel P, et al. Procalcitonin as a marker of severity in septic shock[J]. Langenbecks Arch Sum. 384( 1 ) :33-38.

共引文献195

同被引文献42

  • 1孙成栋,张淑文,董军.脓毒症临床实验免疫指标研究进展[J].中国危重病急救医学,2005,17(12):760-763. 被引量:27
  • 2付红敏,匡凤梧.儿科脓毒症诊治进展[J].实用儿科临床杂志,2007,22(10):798-800. 被引量:15
  • 3邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].第4版.北京:人民卫生出版社,2011:872.
  • 4陆国平.严重脓毒症和脓毒性休克的几个热点问题[J].实用儿科临床杂志,2007,22(22):1687-1689. 被引量:5
  • 5Marchini G, Berggren V, Djilalik Merzoug R, et al. The birth process initiates an acute phase reaction in the fetus newborn infant[J].Acta Paediatr, 2010,89 (9) :1082-1086.
  • 6Whicher 1, Bienvenu J, Mormeret G. Procalcitonirl as anacute phase marker[J].Arm Clin Biochem, 2011,38 (5) :483-493.
  • 7Maruna P, Nedelnikova R, Gurlich R. Physiology and genetics of procalcitonin[J].Physiol Res, 2011,49 ( 1 ) :57-61.
  • 8Brunkhorst FM, Heins U, Forycki ZF. Kinetics of procalcitonin in iatrogenic sepsis[J]. Intensive Care Med, 2011,24 (8) :888-889.
  • 9Hense LM, Volk T, Docke WD, et al. Hyperproca lc-itonemia in patien tswith noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass[J]. Anesthesiology, 2010, 89:93-104.
  • 10Hammers, Meisner F, Hammer C, et al. Use of procalcitonin as indicator of nonviral infection in transplantation and related immunologic diseases[J].Transplant Rev, 2010, 14:52-63.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部